The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series-Reference-Cited by-同舟云学术

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series

Published:2014-06 Issue:6 Volume:8 Page:480-488
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Afzali Anita,Wheat Chelle L.,Hu Jie Kate,Olerud John E.,Lee Scott D.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/8/6/480/1167839/8-6-480.pdf

Reference14 articles.

1. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review;Tracey;Pharmacol Ther,2008

2. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis;Collamer;Semin Arthritis Rheum,2010

3. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature;Cullen;Aliment Pharmacol Ther,2011

4. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease;Fiorino;Aliment Pharmacol Ther,2009

5. Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy;Rahier;Clin Gastroenterol Hepatol,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment;Biomedicines;2024-08-13

2. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study;Digestive and Liver Disease;2024-06

3. EVALUATION OF DRUG SIDE EFFECT PROFILES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE USING TUMOR NECROSIS FACTOR-ALPHA INHIBITORS;Rheumatology Quarterly;2024-05-21

4. Dermal lesions associated with anti-tumor necrosis factor-α therapy in patients with inflammatory bowel disease: findings from an inflammatory bowel disease tertiary center in Poland;Polish Archives of Internal Medicine;2024

5. Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review;Journal of International Medical Research;2023-09